Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：4.8 Date：2025-05-13

International Immunopharmacology

Thiolutin, a novel NLRP3 inflammasome inhibitor, mitigates IgA nephropathy in mice

Products： ELK1921
IF：4.8 Date：2025-07-18

Frontiers in Bioengineering and Biotechnology

The role of PRP in the healing of disc degeneration and the effect of local anesthetics on PRP

Products： ELK1158、 ELK1396
IF：4.8 Date：2026-02-06

Cellular Oncology

ENY2 transcription and export complex 2 subunit deficiency induces nucleolar stress to inhibit tumor progression through NPM1/MDM2/p53-dependent and -independent responses

Products： EQ001
IF：4.8 Date：2025-11-04

Frontiers in Pharmacology

Different degrees of expression of pulmonary fibrosis signs with intratracheal administration of bleomycin at different doses in male SD rats (a study aimed at helping to select the optimal bleomycin dose for modeling pulmonary fibrosis)

Products： ELK8687

< Page of 477 >